Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

  • The following term was not found in PubMed: TomuraN[Author].
1.

Why does sweat lead to the development of itch in atopic dermatitis?

Murota H, Yamaga K, Ono E, Murayama N, Yokozeki H, Katayama I.

Exp Dermatol. 2019 Jun 1. doi: 10.1111/exd.13981. [Epub ahead of print] Review.

PMID:
31152459
2.

Involvement of Periostin in Skin Function and the Pathogenesis of Skin Diseases.

Kuwatsuka Y, Murota H.

Adv Exp Med Biol. 2019;1132:89-98. doi: 10.1007/978-981-13-6657-4_10.

PMID:
31037628
3.

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis.

Koike Y, Fujiki Y, Higuchi M, Fukuchi R, Kuwatsuka S, Murota H.

JAAD Case Rep. 2019 Jan 25;5(2):150-152. doi: 10.1016/j.jdcr.2018.11.016. eCollection 2019 Feb. No abstract available.

4.

Inhibition of angiogenesis and tumor growth by a novel 1,4-naphthoquinone derivative.

Murota H, Shinya T, Nishiuchi A, Sakanaka M, Toda KI, Ogata T, Hayama N, Kimachi T, Takahashi S.

Drug Dev Res. 2019 May;80(3):395-402. doi: 10.1002/ddr.21513. Epub 2019 Jan 11.

PMID:
30632632
5.

Clinical and histopathological significance of PD-1 expression in cutaneous lesions of adult T-cell leukemia-lymphoma.

Higuchi M, Kuwatsuka Y, Murota H, Iwanaga M, Niino D.

Pathol Res Pract. 2019 Jan;215(1):40-49. doi: 10.1016/j.prp.2018.10.001. Epub 2018 Oct 21.

6.

Sweat in the pathogenesis of atopic dermatitis.

Murota H, Yamaga K, Ono E, Katayama I.

Allergol Int. 2018 Oct;67(4):455-459. doi: 10.1016/j.alit.2018.06.003. Epub 2018 Aug 3. Review.

7.

[SWEAT PLAYS A ROLE IN IMMUNE PROTECTION].

Murota H, Tahara M, Shindo S, Ono E, Yamaga K, Katayama I.

Arerugi. 2018;67(6):747-750. doi: 10.15036/arerugi.67.747. Japanese. No abstract available.

PMID:
30022783
8.

Numerous plasmacytoid dendritic cell infiltration in HIV-associated psoriasis relieved only with antiretroviral therapy.

Kuwatsuka S, Koike Y, Asai M, Sato Y, Murota H.

J Dermatol. 2018 Sep;45(9):1126-1129. doi: 10.1111/1346-8138.14525. Epub 2018 Jun 28.

PMID:
29952089
9.

Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.

Wataya-Kaneda M, Ohno Y, Fujita Y, Yokozeki H, Niizeki H, Ogai M, Fukai K, Nagai H, Yoshida Y, Hamada I, Hio T, Shimizu K, Murota H.

JAMA Dermatol. 2018 Jul 1;154(7):781-788. doi: 10.1001/jamadermatol.2018.1408.

10.

Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment.

Ono E, Murota H, Mori Y, Yoshioka Y, Nomura Y, Munetsugu T, Yokozeki H, Katayama I.

PLoS One. 2018 Apr 20;13(4):e0195960. doi: 10.1371/journal.pone.0195960. eCollection 2018.

11.

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA, Boers M, Barbarot S, Stalder JF, Abuabara K, Aoki V, Ardeleanu M, Armstrong J, Bang B, Berents TL, Burton T, Butler L, Chubachi T, Cresswell-Melville A, DeLozier A, Eckert L, Eichenfield L, Flohr C, Futamura M, Gadkari A, Gjerde ES, van Halewijn KF, Hawkes C, Howells L, Howie L, Humphreys R, Ishii HA, Kataoka Y, Katayama I, Kouwenhoven W, Langan SM, Leshem YA, Merhand S, Mina-Osorio P, Murota H, Nakahara T, Nunes FP, Nygaard U, Nygårdas M, Ohya Y, Ono E, Rehbinder E, Rogers NK, Romeijn GLE, Schuttelaar MLA, Sears AV, Simpson MA, Singh JA, Srour J, Stuart B, Svensson Å, Talmo G, Talmo H, Teixeira HD, Thyssen JP, Todd G, Torchet F, Volke A, von Kobyletzki L, Weisshaar E, Wollenberg A, Zaniboni M.

Br J Dermatol. 2018 May;178(5):e332-e341. doi: 10.1111/bjd.16543. Epub 2018 Apr 19.

PMID:
29672835
12.

Attenuated Activation of Homeostatic Glucocorticoid in Keratinocytes Induces Alloknesis via Aberrant Artemin Production.

Matsumoto A, Murota H, Terao M, Katayama I.

J Invest Dermatol. 2018 Jul;138(7):1491-1500. doi: 10.1016/j.jid.2018.02.010. Epub 2018 Feb 21.

13.

Claudin-3 Loss Causes Leakage of Sweat from the Sweat Gland to Contribute to the Pathogenesis of Atopic Dermatitis.

Yamaga K, Murota H, Tamura A, Miyata H, Ohmi M, Kikuta J, Ishii M, Tsukita S, Katayama I.

J Invest Dermatol. 2018 Jun;138(6):1279-1287. doi: 10.1016/j.jid.2017.11.040. Epub 2017 Dec 23.

14.

Periostin in the pathogenesis of skin diseases.

Murota H, Lingli Y, Katayama I.

Cell Mol Life Sci. 2017 Dec;74(23):4321-4328. doi: 10.1007/s00018-017-2647-1. Epub 2017 Sep 15. Review.

PMID:
28916993
15.

Impact of Jumihaidokuto (Shi-Wei-Bai-Du-Tang) on treatment of chronic spontaneous urticaria: A randomized controlled study.

Murota H, Azukizawa H, Katayama I.

Chin J Integr Med. 2017 Aug 17. doi: 10.1007/s11655-017-2950-6. [Epub ahead of print]

PMID:
28819778
16.

Three-dimensional cell shapes and arrangements in human sweat glands as revealed by whole-mount immunostaining.

Kurata R, Futaki S, Nakano I, Fujita F, Tanemura A, Murota H, Katayama I, Okada F, Sekiguchi K.

PLoS One. 2017 Jun 21;12(6):e0178709. doi: 10.1371/journal.pone.0178709. eCollection 2017.

17.

Novel autoantibody against the β2-glycoprotein I/human leucocyte antigen-DR complex in patients with refractory cutaneous ulcers.

Arase N, Tanimura K, Jin H, Yamaoka T, Kishibe M, Nishioka M, Kiyohara E, Tani M, Matsuoka S, Ohmura K, Takasugi K, Yamamoto T, Murota H, Arase H, Katayama I.

Br J Dermatol. 2018 Jan;178(1):272-275. doi: 10.1111/bjd.15571. Epub 2017 Oct 6. No abstract available.

PMID:
28403571
18.

Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.

Kato K, Kawase A, Azukizawa H, Hanafusa T, Nakagawa Y, Murota H, Sakaguchi S, Asada H, Katayama I.

J Dermatol Sci. 2017 Jun;86(3):222-229. doi: 10.1016/j.jdermsci.2017.03.007. Epub 2017 Mar 14.

PMID:
28330775
19.

Successful treatment of a refractory dysbiotic intestinal pseudo-obstruction in a patient with systemic sclerosis-polymyositis overlap syndrome by intravenous immunoglobulin administration possibly related to gut flora normalisation.

Kamei R, Yamaoka T, Ikinaga K, Murota H, Shimizu K, Katayama I.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):214-215. Epub 2017 Jan 31. No abstract available.

PMID:
28229828
20.

Usefulness of Sweat Management for Patients with Adult Atopic Dermatitis, regardless of Sweat Allergy: A Pilot Study.

Kaneko S, Murota H, Murata S, Katayama I, Morita E.

Biomed Res Int. 2017;2017:8746745. doi: 10.1155/2017/8746745. Epub 2017 Jan 22.

Supplemental Content

Loading ...
Support Center